<DOC>
	<DOCNO>NCT00380380</DOCNO>
	<brief_summary>Please note study conduct United States . The purpose study ass acute effect vildagliptin , unapproved drug , reduce post-meal glucose level delay gastric emptying .</brief_summary>
	<brief_title>A Study Assess Acute Effects Vildagliptin Gastric Emptying Patients With Type 2 Diabetes .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Must able complete 1week washout current antidiabetic medication Can take medication may alter gastric motility except cardiac medication stable dose Blood glucose criterion must meet BMI &lt; 40 History type 1 diabetes , diabetes result pancreatic injury , secondary form diabetes Need insulin within 3 month patient thiazolidinediones Significant concommitant disease complication diabetes Patients history gastrointestinal surgery positive gastrointestinal symptons Abnormal liver function test define protocol Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vildagliptin , type 2 diabetes , gastric emptying</keyword>
</DOC>